01
01 · WHAT IT IS
A synthetic regulatory peptide commonly studied for stress-response balance, calm-focus signaling, emotional steadiness, and cognitive-performance research.
Selank is a synthetic heptapeptide analog of tuftsin developed at the Russian Academy of Medical Sciences. It produces an anxiolytic effect comparable to benzodiazepines — without sedation, dependence, cognitive impairment, or withdrawal. Instead of blunting the nervous system, it tunes it: GABA tone up, BDNF up, attention sharpened. Calm and clear at the same time.
A quick, simple breakdown of what SELANK is, why researchers study it, how it works, and what makes it unique.
A synthetic regulatory peptide commonly studied for stress-response balance, calm-focus signaling, emotional steadiness, and cognitive-performance research.
SELANK is studied for its relationship to neurotransmitter signaling, stress-axis modulation, and nervous system balance — especially in models connected to calm focus, mental clarity, and emotional regulation.
SELANK connects multiple high-interest research areas into one compound — stress resilience, cognitive clarity, calm focus, and emotional steadiness research.
Designed to help visitors understand the product before exploring the full research guide.
Think of Selank as a nervous-system tuning fork — a peptide that raises GABA tone and elevates BDNF without flipping the off-switch on cognition.
Benzodiazepines work by amplifying GABA so aggressively that the nervous system shuts down — sedated, foggy, dependent. Selank modulates the same system gently, restoring balance rather than overriding it. It also increases enkephalin levels, the body's own endogenous opioid signaling, which dampens anxiety without creating a high.
The result is the rare combination of calm and focus at the same time. Stress reactivity drops. Mental clarity stays intact. Memory and learning improve through BDNF upregulation.
"Think of Selank as the anxiety dial turned down without the lights dimmed — GABA tone restored, attention preserved, no sedation, no dependence."
It doesn't replace your nervous system's regulation. It restores the upstream balance that lets your nervous system regulate itself.
Chronic anxiety isn't a personality flaw. It's a nervous system stuck in alarm mode — and most pharmacological options trade one problem for another.
The brain's primary inhibitory neurotransmitter weakens with prolonged cortisol exposure. The brake on the nervous system fails — anxiety becomes the default state.
Standard anxiolytics work but sedate, impair memory, and create dependence within weeks. The cure becomes worse than the condition.
When the nervous system is scanning for threats, deep work becomes impossible. The mental bandwidth that should fuel focus is consumed by background fear.
Chronic anxiety lowers BDNF and reduces hippocampal volume — degrading memory, learning, and emotional regulation at the structural level.
Subcutaneous Selank enters circulation, crosses the blood-brain barrier rapidly, and modulates multiple neurochemical systems simultaneously.
Selank increases GABA expression and tone without acting as a direct GABA-A receptor agonist. The brake on the nervous system is sharpened — without the sedation of benzodiazepines.
Selank stabilizes enkephalins — the body's own endogenous opioid peptides. The result is a felt sense of calm without exogenous opioid binding, dependence, or tolerance.
Chronic Selank use elevates BDNF — supporting hippocampal repair, memory consolidation, and the structural recovery of stress-damaged neurons.
Downstream effects of restoring the calm-focus axis.
Comparable anxiolytic effect to benzodiazepines in clinical comparisons — without the fog, drowsiness, or impairment.
Attention and working memory are preserved or improved. Calm doesn't come at the cost of mental sharpness.
Russian trials and decades of clinical use show no withdrawal syndrome on discontinuation. The system regulates itself again.
The startle response, anticipatory anxiety, and rumination loops all soften. Background stress noise quiets.
BDNF upregulation supports hippocampal function. Learning, retention, and recall sharpen over weeks of use.
Mild antidepressant effects from enkephalin stabilization and BDNF elevation. The emotional floor rises.
Reduced anxiety lowers cortisol at night. Sleep architecture improves without the rebound insomnia of benzo withdrawal.
Effects build within an hour subcutaneously. Half-life is short — no accumulation, no hangover, no dependence.
Not biomarkers. The lived experience — day by day — on a consistent daily protocol.
First doses. Subtle drop in background tension. Easier to take a deep breath. Sleep latency may shorten. No sedation, no fog.
Anxiety baseline lower. Stress events feel smaller. Focus during deep work extends. Sleep deeper. Mood floor rises.
Memory and learning sharpen as BDNF accumulates. Social interactions feel easier. Rumination loops break faster.
Stable calm-focus baseline. Cycle off — the regulated state persists without continuous dosing, unlike benzodiazepines.
Exact measurements based on 10 mg vial + 2 mL bacteriostatic water.
Change any input. Every value below updates automatically from the formula. No guessing.
Units, weeks per vial, and vials per cycle — all derived from your 10 mg vial + 2 mL BAC water.
Daily subcutaneous injection. Morning dose preferred. Effects build over 1–2 weeks; full neuroplastic benefit by week 4.
Run 4–6 week cycles, then 2–4 weeks off. Selank does not require tapering — regulated baseline persists between cycles.
One vial may not cover a full standard cycle. Use the standard-cycle supply option to complete the full protocol without interruption.
Educational context only. This is not a guarantee of outcomes.
Selank tunes the nervous system. Paired with the right co-signals, calm, focus, and learning all reinforce each other.
Selank softens anxiety; Semax sharpens focus. Together — calm and focused.
Selank calms daytime; DSIP deepens night. Complete stress-recovery cycle.
Selank quiets acute stress; Epithalon restores the circadian rhythm chronic stress erodes.
Selank is a synthetic heptapeptide analog of tuftsin that produces anxiolytic effects through GABA modulation, enkephalin stabilization, and BDNF upregulation. It reduces anxiety comparable to benzodiazepines — without sedation, dependence, or cognitive impairment.
Acute anxiolytic effect within 1–2 hours of injection. Baseline anxiety reduction over 1–2 weeks. Full neuroplastic effect (memory, learning, BDNF) at 3–4 weeks.
Standard: 1 mg subcutaneously daily, morning. Range 0.5–1.5 mg. Cycle 4–6 weeks on, 2–4 weeks off. No taper required.
Decades of Russian clinical use show an excellent safety profile. Possible: mild fatigue at high doses, brief injection-site irritation. No dependence, no withdrawal, no significant drug interactions documented.
Every batch of our Selank is independently third-party tested for purity (>99%), peptide identity via HPLC and mass spectrometry, and endotoxin levels. A Certificate of Analysis is available for the exact lot you receive. We ship from a temperature-controlled facility in San Diego.
GABA tone weakens. BDNF drops. Hippocampal volume shrinks. The anxiety baseline becomes the new normal. Selank restores the upstream balance your nervous system depends on.
Research-grade Selank, 10 mg per vial. Third-party tested. The anxiolytic without the trade-off.
Explore SelankSource SELANK from Blueprint Peak Performance — third-party tested for >99% purity, cold-chain handled, shipped from San Diego. Educational research use only.
Blueprint Research Guide is editorial. The link above sources research-grade compounds from Blueprint Peak Performance — an independent supplier. For educational purposes only. Research use only — not for human consumption, treatment, or diagnosis.
Printable guide with reconstitution math, unit conversions, research timing, stack planning, storage notes, and quality checks.